Nature Reviews Drug Discovery
| Nature Reviews Drug Discovery | |
|---|---|
 |
|
| Abbreviated title (ISO 4) | (Nat Rev Drug Discov) |
| Discipline | pharmacology biotechnology microbiology |
| Language | English |
| Publication details | |
| Publisher | Nature Publishing Group (international) |
| Publication history | 2002- |
| Frequency | monthly |
| Open access | no |
| Impact factor (2011) |
29.008 |
| Indexing | |
| ISSN | 1474-1776 (print) 1474-1784 (web) |
| Links | |
Nature Reviews Drug Discovery is a review journal with an emphasis on drug discovery and development.[1] With an impact factor of 29.008 in 2011 it is the leading journal in pharmacology/pharmacy and biotechnology/applied microbiology areas.
The reviews are commissioned to leaders in the their specialties (non-commissioned review submissions are discouraged), but are also peer-reviewed after submission. The reviews are supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal accepts peer-reviewed analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[2]
See also [edit]
- Nature Biotechnology, the leading research journal in biotechnology
- Annual Review of Pharmacology and Toxicology and Pharmacological Reviews, two close competitors in the pharmacology area
References [edit]
- ^ Journal Scope : Information : Nature Reviews Drug Discovery. Nature.com (2008-06-20). Retrieved on 2011-06-29.
- ^ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.
  |
This article about a medical journal is a stub. You can help Wikipedia by expanding it.
See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
